The ROE as of November 2024 (TTM) for OncoCyte Corporation (OCX) is -230.32%

According to OncoCyte Corporation’s latest financial reports and current stock price. The company's current ROE is -230.32%. This represents a change of 234.61% compared to the average of -68.83% of the last 4 quarters.

OncoCyte Corporation (OCX) Historical ROE (quarterly & annually)

How has OCX ROE performed in the past?

The mean historical ROE of OncoCyte Corporation over the last ten years is -121.59%. The current -230.32% ROE has changed 89.42% with respect to the historical average. Over the past ten years (40 quarters), OCX's ROE was at its highest in in the December 2014 quarter at 140.32%. The ROE was at its lowest in in the September 2024 quarter at -138.95%.

OncoCyte Corporation (OCX) ROE by Quarter and Year

Discovering the peaks and valleys of OncoCyte Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OncoCyte Corporation (OCX) Average ROE

How has OCX ROE performed in the past?

The current ROE of OncoCyte Corporation (OCX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

OncoCyte Corporation (OCX) ROE vs. Peers

How is OCX’s ROE compared to its peers?

OncoCyte Corporation’s ROE is greater than Burning Rock Biotech Limited (-74.92%), greater than Neuronetics, Inc. (-160.79%), greater than DarioHealth Corp. (-11.69%), less than Genetron Holdings Limited (0%), greater than Sera Prognostics, Inc. (-51.73%), greater than Olink Holding AB (publ) (-7.07%), less than FONAR Corporation (5.78%), less than Castle Biosciences, Inc. (1.47%), greater than Exagen Inc. (-92.58%), greater than Personalis, Inc. (-69.12%), greater than Interpace Biosciences, Inc. (-35.22%), greater than iSpecimen Inc. (-139.25%), less than Trinity Biotech plc (79.32%), greater than Intelligent Bio Solutions Inc. (-144.39%), greater than Biodesix, Inc. (-277.36%), greater than Precipio, Inc. (-23.41%), greater than ProPhase Labs, Inc. (-62.92%), less than Sotera Health Company (16.02%),

Build a custom stock screener for OncoCyte Corporation (OCX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoCyte Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OncoCyte Corporation (OCX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OncoCyte Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.